Biocon Ltd Q3FY25; 89% fall in Profits

Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)

Financial Results:

Biocon Ltd reported Revenues for Q3FY25 of ₹3,821.00 Crores down from ₹3,954.00 Crore year on year, a fall of 3.36%.

Total Expenses for Q3FY25 of ₹3,718.00 Crores down from ₹3,732.00 Crores year on year, a fall of 0.38%.

Consolidated Net Profit of ₹81.00 Crores down 89.24% from ₹753.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹0.21, down 96.18% from ₹5.50 in the same quarter of the previous year.